Global Aortic Stents Grafts Market Size By Type (Abdominal Aortic Stent Graft, Thoracic Aortic Stent Graft), By Application (Hospitals, Ambulatory Surgical Centres), By Region, And Segment Forecasts,...

The Global Aortic Stents Grafts Market was valued at USD 4.1 billion in 2023 and is projected to reach USD 7.9 billion by 2031, growing at a CAGR of 8.3% during the forecast period of 2023–2031. The growing prevalence of aortic aneurysms, coupled with the rising demand for minimally invasive surgical procedures, is driving the expansion of this market. Technological advancements in stent graft design and materials, improved imaging techniques, and the increasing adoption of endovascular aneurysm repair (EVAR) are also contributing to market growth.

Drivers

1. Increasing Prevalence of Aortic Aneurysms

The rising global incidence of thoracic and abdominal aortic aneurysms, especially among the aging population, is a key factor driving the demand for stent grafts.

2. Advancements in Endovascular Techniques

Continuous improvements in EVAR and thoracic endovascular aortic repair (TEVAR) technologies have made these procedures safer, more precise, and suitable for a broader patient population.

3. Preference for Minimally Invasive Procedures

Patients and healthcare providers increasingly prefer less invasive treatment options that reduce recovery time, lower surgical risks, and decrease hospital stays.

Restraints

1. High Cost of Devices and Procedures

The significant cost associated with aortic stent grafts and the endovascular procedure itself can be a barrier, particularly in developing regions with constrained healthcare budgets.

2. Risk of Post-operative Complications

Despite being minimally invasive, complications such as endoleaks, graft migration, and infection remain concerns, affecting clinical outcomes and market trust.

Opportunity

1. Emerging Markets Expansion

Regions such as Asia-Pacific and Latin America present untapped opportunities due to improving healthcare infrastructure, growing awareness, and rising investment in medical technologies.

2. Technological Innovation in Graft Materials and Designs

Innovations such as fenestrated and branched stent grafts designed to treat complex aneurysms are creating new growth avenues for manufacturers.

Market by System Type Insights

Based on system type, the Abdominal Aortic Stent Grafts segment accounted for the largest market share in 2023. The dominance is attributed to the high prevalence of abdominal aortic aneurysms and the wide adoption of EVAR as the standard treatment approach. Meanwhile, the Thoracic Aortic Stent Grafts segment is projected to register the fastest growth during the forecast period, driven by advancements in TEVAR procedures and increased screening rates.

Market by End-use Insights

Hospitals remained the primary end-use segment in 2023, owing to the availability of advanced surgical infrastructure and specialized vascular surgeons. However, specialty clinics and ambulatory surgical centers (ASCs) are expected to witness rapid growth due to the shift toward outpatient care and the miniaturization of stent graft delivery systems.

Market by Regional Insights

North America held the largest share of the global aortic stents grafts market in 2023, supported by high awareness, advanced healthcare systems, and favorable reimbursement policies. Europe followed closely, with robust demand in Germany, France, and the UK. Asia-Pacific is expected to grow at the fastest CAGR during the forecast period, driven by rising healthcare expenditure, an aging population, and increasing access to advanced treatment options in countries like China, India, and Japan.

Competitive Scenario

Key players in the Global Aortic Stents Grafts Market include:

Medtronic plc

Cook Medical

W. L. Gore & Associates

Terumo Corporation

Endologix LLC

Cardinal Health, Inc.

MicroPort Scientific Corporation

Lombard Medical Technologies

Boston Scientific Corporation

Becton, Dickinson and Company (BD)

These companies are focused on product innovations, clinical trial expansions, and strategic partnerships to strengthen their market footprint. For instance:

In 2023, Medtronic received FDA approval for its next-generation thoracic stent graft system designed for complex aortic anatomies.

In 2024, Cook Medical expanded its product reach in Asia-Pacific by launching region-specific EVAR systems tailored to local anatomical variations.

Scope of Work – Global Aortic Stents Grafts Market

Report Metric Details

Market Size (2023) USD 4.1 billion

Projected Market Size (2031) USD 7.9 billion

CAGR (2023–2031) 8.3%

Market Segments By System Type (Abdominal, Thoracic), By End-use (Hospitals, ASCs, Clinics)

Growth Drivers Increasing prevalence of aortic aneurysms, preference for minimally invasive surgeries

Opportunities Expansion into emerging markets, innovation in stent graft design

Key Market Developments

2023: W. L. Gore & Associates launched a new low-profile thoracic stent graft to facilitate easier navigation through tortuous anatomy.

2024: Terumo Corporation announced a partnership with a leading cardiovascular center in Japan to conduct long-term studies on next-generation stent grafts.

2025: Endologix LLC introduced a branched endograft system designed for treating juxtarenal aneurysms, expanding its product capabilities.

FAQs

1) What is the current market size of the Global Aortic Stents Grafts Market?

The market size in 2023 was valued at USD 4.1 billion.

2) What is the major growth driver of the Global Aortic Stents Grafts Market?

The key driver is the increasing prevalence of aortic aneurysms and the growing demand for minimally invasive treatment options.

3) Which is the largest region during the forecast period in the Global Aortic Stents Grafts Market?

North America is expected to remain the dominant region due to advanced healthcare systems and high procedure volumes.

4) Which segment accounted for the largest market share in Global Aortic Stents Grafts Market?

The Abdominal Aortic Stent Grafts segment accounted for the largest share in 2023.

5) Who are the key market players in the Global Aortic Stents Grafts Market?

Key players include Medtronic plc, Cook Medical, W. L. Gore & Associates, Terumo Corporation, and Endologix LLC.